QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
12.31
-0.26 (-2.07%)
Oct 7, 2026, 4:00 PM EDT - Market closed
QuidelOrtho Revenue
QuidelOrtho had revenue of $630.90M in the quarter ending June 28, 2026, with 2.77% growth. This brings the company's revenue in the last twelve months to $2.67B, down -2.46% year-over-year. In the year 2025, QuidelOrtho had annual revenue of $2.73B, down -1.89%. That makes QuidelOrtho the 4,097th largest company in the world by revenue and 1,126th in the United States.
Revenue (ttm)
$2.67B
Revenue Growth
-2.46%
P/S Ratio
0.32
Revenue / Employee
$411,415
Employees
6,500
Market Cap
844.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.73B | -52.70M | -1.89% |
| Dec 31, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.36B |
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| Lumexa Imaging Holdings | 1.04B |
| Varex Imaging | 865.00M |
| InMode | 374.63M |
| SI-BONE | 213.60M |
| Cytek Biosciences | 206.71M |
QDEL News
- 23 hours ago - QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations - PRNewsWire
- 13 days ago - Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment - PRNewsWire
- 5 weeks ago - Faster Answers, Better Decisions: ADLM 2026 Highlights - PRNewsWire
- 2 months ago - QuidelOrtho Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - QuidelOrtho Earnings release: Q2 2026 - Filings
- 2 months ago - QuidelOrtho Quarterly report: Q2 2026 - Filings
- 2 months ago - QuidelOrtho Slides: Q2 2026 - Filings
- 2 months ago - QuidelOrtho reports Q2 adjusted EPS 13c, consensus (5c) - TheFly